Literature DB >> 6610398

Studies in homosexual patients with and without lymphadenopathy. Relationships to the acquired immune deficiency syndrome.

R D deShazo, J P Penico, G A Pankey, J A Nordberg, J L Newton, B Bozelka, L M Cortez, J R Dalovisio.   

Abstract

We studied the immunologic function of 19 sexually active homosexual men, ten of whom had persistent lymphadenopathy. Analysis of mononuclear cell populations distinguished homosexuals from heterosexual controls since, as a group, homosexuals had increased percentages of natural killer cells (Leu 7+), decreased helper-inducer T lymphocytes (OKT-4+), increased suppressor/cytotoxic (OKT-8+) T lymphocytes, low OKT-4:OKT-8 ratios, and depressed mitogenic responses. Homosexuals without lymphadenopathy were distinguishable from controls by increased percentages of Ia+ cells, decreased OKT-4+ cells, and decreased OKT-4:OKT-8 ratios. Four had positive findings simultaneously for hepatitis B surface antigen (HBsAg) and surface antibody, and five had positive findings for HBsAg alone. Homosexuals with lymphadenopathy were distinguishable from controls by increased percentages of Leu 7+ cells, increased total lymphocyte numbers per cubic millimeter, decreased percentages of both OKT-4+ and OKT-8+ cells, abnormal OKT-4:OKT-8 ratios, and depressed mitogenic responses. Only histories of larger numbers of sexually acquired diseases, higher numbers of OKT-8+ cells per cubic millimeter, and lower mitogenic responses in homosexuals with lymphadenopathy distinguished this group from homosexuals without lymphadenopathy. Furthermore, none of the nine patients tested in this group was HBsAg positive. We conclude that homosexuals without lymphadenopathy are distinguishable from those with lymphadenopathy by both immunologic and serologic abnormalities.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6610398

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  6 in total

1.  The Vancouver Lymphadenopathy-AIDS Study: 3. Relation of HTLV-III seropositivity, immune status and lymphadenopathy.

Authors:  W J Boyko; M T Schechter; E Jeffries; B Douglas; M Maynard; M O'Shaughnessy
Journal:  Can Med Assoc J       Date:  1985-07-01       Impact factor: 8.262

2.  Alterations in cytotoxic and phenotypic subsets of natural killer cells in acquired immune deficiency syndrome (AIDS).

Authors:  S Plaeger-Marshall; C A Spina; J V Giorgi; R Mitsuyasu; P Wolfe; M Gottlieb; G Beall
Journal:  J Clin Immunol       Date:  1987-01       Impact factor: 8.317

3.  Increased interleukin-2 receptor expression after mitogen stimulation on CD4- and CD8-positive lymphocytes and decreased interleukin-2 production in HTLV-III antibody-positive symptomatic individuals.

Authors:  P C Creemers; M O'Shaughnessy; W J Boyko
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

4.  Diagnostic utility of lymphocyte subset analysis in AIDS case finding.

Authors:  W J Boyko; M T Schechter; A MacLeod; B Douglas; M Maynard; R Sharp; B Wiggs
Journal:  CMAJ       Date:  1986-05-01       Impact factor: 8.262

5.  The Vancouver Lymphadenopathy-AIDS Study: 5. Antecedent behavioural, clinical and laboratory findings in patients with AIDS and HIV-seropositive controls.

Authors:  W J Boyko; M T Schechter; K J Craib; P Constance; R Nitz; S Fay; A McLeod; M O'Shaughnessy
Journal:  CMAJ       Date:  1986-10-15       Impact factor: 8.262

6.  Immunological and virological investigation in patients with lymphoadenopathy syndrome and in a population at risk for acquired immunodeficiency syndrome (AIDS), with particular focus on the detection of antibodies to human T-lymphotropic retroviruses (HTLV III).

Authors:  M C Sirianni; P Rossi; B Scarpati; G Ragona; R Seminara; G Bonomo; F Aiuti
Journal:  J Clin Immunol       Date:  1985-07       Impact factor: 8.317

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.